Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Engulfment and cell motility protein 1
(
ELMO1
) is part of a guanine nucleotide exchange factor for Ras-related C3 botulinum toxin substrate (Rac), and
ELMO1
polymorphisms were identified to be associated with diabetic nephropathy in genome-wide association studies. We generated a set of Akita Ins2C96Y diabetic mice having 5 graded cardiac mRNA levels of
ELMO1
from 30% to 200% of normal and found that severe dilated cardiomyopathy develops in
ELMO1
-hypermorphic mice independent of renal function at age 16 weeks, whereas
ELMO1
-hypomorphic mice were completely protected. As
ELMO1
expression increased, reactive oxygen species indicators, dissociation of the intercalated disc, mitochondrial fragmentation/dysfunction, cleaved
caspase-3
levels, and actin polymerization increased in hearts from Akita mice. Cardiomyocyte-specific overexpression in otherwise
ELMO1
-hypomorphic Akita mice was sufficient to promote cardiomyopathy. Cardiac Rac1 activity was positively correlated with the
ELMO1
levels, and oral administration of a pan-Rac inhibitor, EHT1864, partially mitigated cardiomyopathy of the
ELMO1
hypermorphs. Disrupting Nox4, a Rac-independent NADPH oxidase, also partially mitigated it. In contrast, a pan-NADPH oxidase inhibitor, VAS3947, markedly prevented cardiomyopathy. Our data demonstrate that in diabetes mellitus
ELMO1
is the "rate-limiting" factor of reactive oxygen species production via both Rac-dependent and Rac-independent NADPH oxidases, which in turn trigger cellular signaling cascades toward cardiomyopathy.
...
PMID:Engulfment and cell motility protein 1 potentiates diabetic cardiomyopathy via Rac-dependent and Rac-independent ROS production. 3121 60